USANA Health Sciences (USNA) Investor presentation summary

Strategic transformation and growth drivers

• Evolving from a direct selling foundation to a diversified omnichannel health and wellness platform, with Hiya and Rise Wellness driving expansion into DTC, e-commerce, and retail channels.

• Emerging brands expected to contribute ~23% of FY2026 revenue, diversifying the revenue base beyond direct selling.

• Hiya and Rise Wellness target high-growth consumer segments, expanding the customer base to families, younger consumers, and retail-first shoppers.

• Strategic investments and commercial execution aim to stabilize and return the core nutritional business to growth.

• Global presence spans 25 international markets, with increasing domestic revenue share and geographic diversification.

Financial performance and outlook

• FY2026 consolidated net sales guidance: $925M–$1.0B; adjusted EBITDA: $101M–$109M; adjusted diluted EPS: $1.95–$2.29.

• Hiya and Rise Wellness projected to deliver $140M–$155M and $65M–$80M in net sales, respectively, in FY2026.

• Core Nutritional business expected to generate $720M–$765M in net sales, with favorable currency impact and one less week of operations compared to FY2025.

• Strong balance sheet with $162.8M in cash and equivalents, $543.6M in stockholders’ equity, and low leverage as of April 2026.

• Capital allocation priorities include internal investment, disciplined M&A, and share repurchases.

Brand and product strategy

• Hiya: Clean-label, sugar-free daily vitamins for kids, leveraging a digital-first subscription model and expanding into retail and international markets.

• Rise Wellness: Clean, simple protein products in multiple formats, scaling through national retail, club, and DTC channels.

• Both brands emphasize product innovation, omnichannel distribution, and cross-selling to extend customer lifetime value.

• Core Nutritional business leverages science-led R&D, in-house manufacturing, and a global direct selling network.

• Strategic initiatives focus on sales force reinvigoration, accelerated product innovation, and technology modernization.